Evidence map›Paper›PMID 40216588›Full record

ReviewChemPlusChem2025

Sustainable Synthesis, Characterization, Cellular Effects of Gold Nanoparticles and Their Applications as Therapeutics in Cancer Therapy.

Youfeng Yue, Akihiro Moriyama, Marie Mita, Yue Yu

Abstract readReview
In one paragraph

Review in ChemPlusChem, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Youfeng YueCore Electronics Technology Research Institute, National Institute of Advanced Industrial Science and Technology (AIST), Tsukuba, Ibaraki, 305-8565, Japan.ORCID 0000-0002-5600-1112
Akihiro MoriyamaResearch Institute of Science for Safety and Sustainability, National Institute of Advanced Industrial Science and Technology (AIST), Tsukuba, Ibaraki, 305-8569, Japan.
Marie MitaMolecular Biosystems Research Institute, National Institute of Advanced Industrial Science and Technology (AIST), Ikeda, Osaka, 563-8577, Japan.
Yue YuMolecular Biosystems Research Institute, National Institute of Advanced Industrial Science and Technology (AIST), Tsukuba, Ibaraki, 305-8566, Japan.

Funding

AIST
6 · The paper itself

Abstract

In recent years, gold nanoparticles (AuNPs) have attracted much attention due to their extensive applications in fields such as biomedicine, electronics, catalysis, and environmental science. However, traditional chemical methods for AuNPs synthesis present certain challenges, such as the use of harsh chemicals and high energy consumption. These limitations have led to the development of alternative, sustainable synthesis methods that are efficient, cost-effective, and environmentally friendly. These methods focus on the principle of green chemistry, utilizing renewable biomass sources (e.g., plant tissues, bacteria, fungi, and algae) and nontoxic solvents to minimize environmental impact. Biomolecules derived from biomass, such as polyphenols, proteins, and unsaturated fatty acids, enable the synthesis of AuNPs under mild and eco-friendly conditions. This review provides a comprehensive overview of recent advancements in the sustainable synthesis and applications of AuNPs. It summarizes the specific active compounds that drive the reduction and stabilization of AuNPs. It also explores the characterization techniques and underlying mechanisms involved in synthesis. Furthermore, their cellular effects and long-term safety are discussed, along with their extensive applications in biomedical fields, including bioimaging and cancer therapies. Finally, the potential of AuNPs is summarized, highlighting future perspectives as well as emerging opportunities and challenges in biological applications.

Indexed as

Antineoplastic AgentsGoldMetal NanoparticlesNeoplasmsAnimalsGreen Chemistry TechnologyHumansAntineoplastic AgentsGoldbioimagingsbiomoleculescancer therapiescellular effectsgold nanoparticlessurface modifications

Identifiers

PMID40216588
PMCPMC12261063

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.